1. The pre-and post-junctional a-adrenoceptor blocking agent, phentolamine, was given by intravenous infusion to eight healthy volunteers during rest, forearm exercise and post-exercise.
Introduction
In peripheral blood vessels innervated by sympathetic neurons, stimulation of postjunctional a-adrenoceptors brings about contraction of the vascular smooth muscle cells. Conversely, a-adrenoceptor blocking agents produce peripheral vasodilatation through blockade of the vascular a-adrenoceptors. The vasodilatating effect of an a-adrenoceptor blocking agent may be expected to disappear when adrenergic vasoconstrictor activity recedes in an exercising muscle group.
Prazosin and phentolamine are competitive postjunctional a-adrenoceptor blocking drugs [l, 21. Phentolamine also blocks prejunctional a-adrenoceptors, thus increasing the release of noradrenaline from sympathetic nerve endings [3] . Several studies have demonstrated the vasodilatator effect of phentolamine [4-71. A study on digital arteries in vitro showed that phentolamine competitively and phenoxybenzamine non-competitively antagonized the vasoconstriction induced by a-adrenoceptor stimulation with noradrenaline but phentolamine had no effect on the non-specific vasoconstrictor activity of barium chloride [ 8 ] .
In the present study phentolamine was administered by intravenous infusion to young healthy subjects to assess its haemodynamic and metabolic effects at rest and during forearm exercise.
Methods

Subjects
The study involved eight healthy non-obese men. Median weight was 70 kg (range 60-79 kg), 0. J. Hartling and J. nap-Jensen median age 28 years (range 19-38 years). The subjects consented to participate in the study having been informed of its nature, purpose and possible risks. The study complied with the code of ethics of the Declaration of Helsinki. Some days before the investigation we tested each subject's working capacity on a springloaded hand ergometer [9] adjusted so that the work load could be performed for 10 min. On the same occasion, the subjects were familiarized with the laboratory surroundings and the techniques and personnel involved in the investigation.
Techniques
By the Seldinger technique a polyethylene catheter (inner diameter 0.61 mm) was inserted percutaneously in the right brachial artery at the level of the humeral intercondylar line and was advanced 5 cm upstream. A Teflon catheter was inserted into a deep cubital vein of the right arm, and was advanced 5 cm in the distal direction. The arterial catheter was kept patent by injecting small amounts of sodium chloride solution (1 54 mmol/l: saline). The venous catheter was infused with saline at a rate of 0.55 ml/min. Heparin was not used.
Forearm blood flow at rest was measured by means of venous occlusion strain-gauge plethysmography, with a collecting pressure of 50 mmHg, and during forearm exercise by the indicatordilution technique after an intra-arterial bolus injection of 1311-labelled human albumin [lo] . The bolus volume was 0.8 ml containing about 2 pCi of '311-labelled albumin. To protect the thyroid gland from possible free 1311 the subjects were given 100 mg of potassium iodide tablets thrice daily on the day before and on the day of the study. The forearm volume was determined by water displacement.
Intra-arterial blood pressure was continuously recorded, except when blood samples were collected, with an Elema-Schonander EMT 35 pressure transducer. ECG was continuously recorded on a direct writing recorder. Forearm vascular resistance was calculated by dividing the mean blood pressure by the blood flow.
Blood samples for the determination of oxygen saturation and substrate concentrations were collected simultaneously from the brachial artery and the deep vein. Blood oxygen saturationand haemoglobin concentration were determined spectrophotometrically, and packed cell volume was determined by centrifugation [l 1 1. Blood glucose, lactate, alanine and glycerol were determined enzymatically in aliquots of arterial and venous blood. Samples were deproteinized in ice-cold perchloric acid immediately after collection [ll-131.
Free fatty acids and triglycerides were determined in serum [ll] . One minute before each blood sample was taken a wrist cuff was inflated to a suprasystolic pressure and was maintained at this level during the sampling and subsequent blood flow measurement to exclude the hand from the circulation.
Procedure
The subject arrived at the laboratory in the morning after an overnight fast and not having smoked for 12 h. The study was performed in an air-conditioned room maintained at 21 2 1°C. After we had placed the intravascular catheters, the subject rested recumbently for half an hour. During a subsequent period of 30 min supine rest forearm blood flow was measured, and at the end of this period blood samples were collected. Then the subjects, remaining in the supine position, performed right forearm dynamic exercise for 10 min at a rate of 50 contractions/min (range of hand ergometer work load 1.0-1.3 W). During the last 4 min of exercise a wrist cuff was inflated to suprasystolic pressure. After a recovery period of 30 min a priming dose of 5 mg of phentolamine was given intravenously in the course of 2 min, followed by infusion at a rate of 0.44 mg/min during the rest of the study, that is 30 min rest, 10 min forearm exercise and 30 min recovery. Thus the total dose of phentolamine amounted to about 35 mg. In the control period and after the start of phentolamine infusion, blood samples were collected repeatedly at rest, during exercise and during recovery.
Statistical analysis
The significance of differences between paired observations was tested by Student's t-test [ 141.
To compare time curves a two-way analysis of variance was employed with correction for correlated errors [ 14, 151. Differences were considered to be significant if a 2 P value below 0.05 was obtained, denoted as P < 0.05.
Results
The intravenous infusion of phentolamine caused an increase in the heart rate throughout the study (Fig. 1) . The mean blood pressure did not change significantly except at the end of the exercise period, where a slight fall in mean blood pressure occurred (Table 1) . Systolic blood pressure was unchanged by phentolamine, but there was a small decrease in diastolic blood pressure (Fig. 1) .
During phentolamine infusion forearm blood flow increased at rest (P<O.Ol) and in the recovery (Fig. 1, Table 1) . Correspondingly, forearm vascular resistance showed a fall at rest and in the recovery period during phentolamine administration, but was not changed during exercise ( Table  1 ). All of the subjects spontaneously complained of a stuffed nose shortly after the beginning of phentolamine infusion. Probably, this could be taken as a sign of peripheral vasodilatation.
The arterial blood glucose concentration increased slightly during phentolamine infusion (Fig.  2) . Arterial blood lactate did not change significantly (Fig. 2) . The blood concentration of alanine was lower during phentolamine (Fig. 2) .
Arterial concentrations of glycerol and free fatty acids were raised and the concentration of triglycerides was lowered during phentolamine administration (Fig. 3) .
Forearm exchange of oxygen, glucose and lactate did not change significantly during phentolamine infusion (Table 1 ). There was a large scatter of the values of forearm turnover of alanine, glycerol, free fatty acids and triglycerides, and no consistently significant changes could be identified ( Table 1) .
Discussion
Haemodynamic effects
The vasodilator capacity of phentolamine was shown by the increase in forearm blood flow and decrease in vascular resistance at rest and postexercise. No doubt the vasodilatation involved other tissues too, as suggested by the feeling of a stuffed nose by all of the subjects (cf. Green et al. [6] ). However, during forearm exercise the forearm blood flow and vascular resistance were not influenced by phentolamine. Thus the vasodilatation produced by phentolamine in resting muscle was not apparent when that same muscle group was exercised, but reappeared during recovery. This is a main finding that accords with the concept that adrenergic control of muscle blood flow plays a subordinate role in exercising tissues [16] [17] [18] . The degree of 'functional sympatholysis' appears to be proportional to the intensity of the muscular exercise [16, 18] . In contrast to the present findings the vasodilator diazoxide augmented the blood flow through the forearm exercised at similar work loads, undoubtedly by virtue of the non-specific potential of this drug for relaxation of vascular smooth muscle [ 191.
Normotensive man and animal are less responsive to the hypotensive effects of vasodilators than are hypertensive species [ 19-21] . Accordingly, the a-adrenoceptor blocking agent, phentolamine, produced only a small reduction in arterial blood pressure. One reason for a minimal blood pressure reduction may be a greater baroreceptor sensitivity in normotensive than in hypertensive subjects [22] . Thus the sustained increase in heart rate during phentolamine infusion, and a parallel increase in cardiac output [23, 24] , can be looked upon as a counter-regulation elicited by phentolamine's hypotensive propensity. This counter-regulation is undoubtedly brought about by an increased sympathetic tone, with an increased release of noradrenaline during phentolamine infusion [25-271. LE 1 . .-I rrcrial blood pressure, forearm blood flow, forearm vascular resistance and forearm exchange of substrates before and during ph infusion up nic;in values t S E M a r e presented. A negative value means a net release o f t h e substrate. Significance of differences between values during phentolamine infusion: * P < 0.05; ** P < 0.01. (-) and during (---) intravenous infusion of phentolamine. Vertical bars denote 1 SEM. Significance of difference between curves: * P < 0.05; N.S. not significant.
*
The hypotensive effect of phentolamine is augmented when reflex cardiac activity is blocked with a P-adrenoceptor antagonist [24] . Likewise, combined blockade of a-and 0-adrenoceptors with labetalol produced a clear-cut blood pressure reduction both in normal subjects and in hypertensive patients [ 10,281. (-) and during (---) 
